[EN] CONDENSED ISOXAZOLINE DERIVATIVES AND THEIR USE AS HERBICIDES<br/>[FR] DÉRIVÉS D'ISOXAZOLINE CONDENSÉS ET LEUR UTILISATION COMME HERBICIDES
申请人:BASF SE
公开号:WO2021224040A1
公开(公告)日:2021-11-11
The invention relates to compounds of formula (I), and their use as herbicides. In said formula, R1 to R6 represent groups such as hydrogen, halo-gen or organic groups such as alkyl, alkenyl, alkynyl, or alkoxy; W is a bicyclic heterocycle; X is a bond or a divalent unit; Y is hydrogen, cyano, hydroxyl or a linear or cyclic organic group. The invention further refers to a composition comprising such compound and to the use thereof for controlling unwanted vegetation.
4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof
申请人:Jung Jae-Kyu
公开号:US20070161701A1
公开(公告)日:2007-07-12
System for selecting a colour shade comprising a very small number of colour display cards with mixed shades of two or more colours. The system comprises means for selecting one shade among mixed shades, means for presenting the selected mixed shade as well as means for specifying the selected mixed shade for making paint in the desired colour tone.
A process for preparing a polyolefin by homopolymerizing or copolymerizing an olefin or olefins using a catalyst comprising a solid catalyst component and an organometallic compound, said solid catalyst component being obtained by contacting at least a titanium compound and/or a vanadium compound with a solid material (a), said solid material (a) being obtained by contacting the following components (1), (2) and (3) with one another:
(1) a silicon oxide and/or an aluminum oxide,
(2) a magnesium halide, and
(3) an organometallic compound.
TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS
申请人:ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD.
公开号:US20210292334A1
公开(公告)日:2021-09-23
The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyperfunctioning, such as certain types cancers. Compounds of formula (1) and methods of preparing the compounds are disclosed in the invention.